Newsroom

Sorted by: Latest

-

Sprouts Farmers Market, Inc. Reports Fourth Quarter and Full Year 2025 Results

PHOENIX--(BUSINESS WIRE)--Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 13-week fourth quarter and 52-week year ending December 28, 2025. “Sprouts delivered strong growth in 2025," said Jack Sinclair, chief executive officer of Sprouts Farmers Market. "These results were a testament to the strength of our business and our team's commitment to serving our unique target customer. We are committed to helping our customers live and eat better and remain laser focused on...
-

Alarm.com Reports Fourth Quarter and Full Year 2025 Results

TYSONS, Va.--(BUSINESS WIRE)--Alarm.com Holdings, Inc. (Nasdaq: ALRM), the leading platform for intelligently connected properties, today reported financial results for its fourth quarter and full year ended December 31, 2025. Alarm.com also provided its financial outlook for SaaS and license revenue for the first quarter of 2026 and guidance for the full year 2026. Fourth Quarter 2025 Financial Results as Compared to Fourth Quarter 2024 SaaS and license revenue increased 8.8% to $180.2 million...
-

AM Best Revisa Perspectivas a Positivas; Afirma Calificaciones Crediticias de Aliado Seguros, S.A.

CIUDAD DE MÉXICO--(BUSINESS WIRE)--AM Best ha revisado las perspectivas a positivas de estables y ha afirmado la Calificación de Fortaleza Financiera (FSR, por sus siglas en inglés) de B++ (Buena), y la Calificación Crediticia de Emisor (ICR, por sus siglas en inglés) de Largo Plazo de “bbb+” (Buena) de Aliado Seguros, S.A. (Aliado) (Panamá). Las Calificaciones Crediticias (calificaciones) de Aliado reflejan la fortaleza de su balance, la cual AM Best evalúa como la más fuerte, así como su dese...
-

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results for the full year ended December 31, 2025, and discuss recent business updates. Listeners...
-

Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update. “2025 marked a year of meaningful advancement for Travere, strengthening both our commercial execution and long-term growth outlook,” said Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics. “In IgA nephropathy, continued adoption of FILSPARI underscores its foundational positioning and the posi...
-

TriSalus Life Sciences Proposes Public Offering

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering are to be sold by TriSalus. In addition, TriSalus i...
-

Rimini Street Announces Fiscal Fourth Quarter and Annual 2025 Financial and Operating Results

LAS VEGAS--(BUSINESS WIRE)--Rimini Street, Inc., (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the 2025 fourth quarter and fiscal year ended December 31, 2025. “Our fourth quarter results reflect solid execution and continued accelerating sales growth, adjusted for the Oracle PeopleSoft support and...
-

Armada Acquisition Corp. III Announces Closing of $248.5 Million Initial Public Offering

PHILADELPHIA--(BUSINESS WIRE)--Armada Acquisition Corp. III (the “Company” or “AACI”) announced today the closing of its initial public offering of 24,850,000 units, including partial exercise of an over-allotment option, at $10.00 per unit. The offering resulted in gross proceeds to the Company of $248,500,000. The units began trading on the Nasdaq Global Market (“Nasdaq”) on February 18, 2026 under the ticker symbol "AACIU". Each unit consists of one Class A ordinary share and one-half of one...
-

Perdoceo Education Corporation Reports Fourth Quarter and Full Year 2025 Results

SCHAUMBURG, Ill.--(BUSINESS WIRE)--PERDOCEO EDUCATION CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS...
-

AM Best Revises Outlooks to Positive; Affirms Credit Ratings of Aliado Seguros S.A.

MEXICO CITY--(BUSINESS WIRE)--AM Best has revised the outlooks to positive from stable and affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of Aliado Seguros S.A. (Aliado) (Panama). These Credit Ratings (ratings) reflect Aliado’s balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM). The outlook revisions to p...